Sunday, 19 November 2017

 

Kemin to Present Findings at Popular Gut Health Symposium

Results of replacing antibiotic growth promoter in poultry to be shared in poster session
agrilife24.com, International desk:Participants at the annual Gut Health in Production of Food Animals Symposium will have three days focused on the role of gut health in animal production and the dynamic and essential role gut health plays in it. Among the insights shared will be a special abstract by Dr. Chan Poh Soon and Dr. Tihn Nguygen of Kemin, who respectively serve as the Product Manager for Antibiotic Alternative platforms and the Technical Service Manager for Animal Health.

Drs. Chan and Nguyen were selected to share an abstract and related poster entitled, Replacing enramycin with a probiotic, Bacillus subtilis PB6, in commercial broiler chickens (Cobb 500). The presentation will include results obtained from two commercial trials conducted by Kemin this year.

“One question we hear repeatedly is if there is an effective alternative to antibiotic growth promoter in treating important poultry diseases, such as necrotic enteritis,” said Dr. Chan of Kemin. “The answer is yes, as we learned through trials where Bacillus subtilis PB6, more commonly known by the brand name CLOSTAT®, was used as an alternative to control Clostridium perfringens infection in poultry. The broiler performance was not compromised and we are looking forward to sharing the results with those who are seeking options for antibiotic-free farming.”

The annual Gut Health in Production of Food Animals Symposium is being held in St. Louis, Missouri, November 14-16. Started in 2012 at the encouragement of the U.S. Department of Agriculture with 40 attendees, today the popular Symposium is capped at 175 participants to ensure full engagement in scientific discussions and the exchange of opinions between university, government, and industry researchers. Per event organizers, this year’s symposium is sold out.
More information related to the Kemin poster presentation and trial are available by contacting Dr Chan Poh Soon, +65 6490 4004,

-Press Release